NEW YORK (GenomeWeb) – Transgenomic today announced that it has signed distributors in China and Japan for its ICEme mutation enrichment kit.
Under the terms of the agreements, Spectron Scientific will distribute the product in China and Sowa Trading Company will distribute it in Japan.
"Asia represents important and growing markets for cancer research, and our ICEme Kits will allow researchers in China and Japan to use the sequencing platforms already in their labs to conduct sophisticated genetic analyses to accelerate their cancer research and drug discovery programs," Transgenomic President and CEO Paul Kinnon said in a statement. "We expect to announce additional distributors in other key territories soon."
Financial and other details of the agreements were not disclosed.
The mutation enrichment kits, launched in July, are based on Transgenomic's MX-ICP technology for high sensitivity mutation detection. The kits work on most patient samples, the firm said, including tissue, blood, plasma, urine, and other fluids, and enrich 17 clinically relevant and actionable mutations associated with cancers.